Synthesis, in vitro hydrolysis, bioanalytical method development and pharmacokinetic study of an amide Prodrug of Ibuprofen

Ritu Ojha, Kunal Nepali, Rohit Goyal, Kanaya Lal Dhar, Tilakraj Bhardwaj

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Ibuprofen, one of the most widely used non-steroidal anti-inflammatory drug, is an aryl acetic acid derivative, which is an active ingredient in variety of oral formulations such as tablets, gel, pellets, and syrup dosage forms used worldwide. Gastric side effects of ibuprofen are attributed to the presence of free - COOH group and inhibition of endogenous prostaglandins. In recent years, considerable research has been directed at designing prodrugs of ibuprofen with reduced gastro-intestinal toxicity. Numerous ester and amide prodrugs of ibuprofen have been reported. With this background, the present work involves the synthesis, analytical method development, in-vitro hydrolysis, bioanalytical method development, and pharmacokinetics study of an amide prodrug of Ibuprofen coded as TRB-559.

Original languageEnglish
Pages (from-to)261-271
Number of pages11
JournalCurrent Pharmaceutical Analysis
Volume8
Issue number3
DOIs
Publication statusPublished - Jul 23 2012
Externally publishedYes

Fingerprint

Pharmacokinetics
Ibuprofen
Prodrugs
Amides
Hydrolysis
Dosage Forms
Acetic Acid
Tablets
Prostaglandins
Toxicity
Stomach
Esters
Anti-Inflammatory Agents
Gels
In Vitro Techniques
Derivatives
Research
Pharmaceutical Preparations

Keywords

  • Analgesic
  • Bioanalytical Method Development
  • Drug Release
  • In Vitro Hydrolysis
  • Non- Steroidal Antiinflammatory Drugs
  • Pharmacokinetics
  • Pharmacokinetics Study
  • Prodrug
  • Prostaglandins
  • Validation

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Molecular Medicine
  • Biochemistry
  • Biophysics

Cite this

Synthesis, in vitro hydrolysis, bioanalytical method development and pharmacokinetic study of an amide Prodrug of Ibuprofen. / Ojha, Ritu; Nepali, Kunal; Goyal, Rohit; Dhar, Kanaya Lal; Bhardwaj, Tilakraj.

In: Current Pharmaceutical Analysis, Vol. 8, No. 3, 23.07.2012, p. 261-271.

Research output: Contribution to journalArticle

@article{e5c5e94d8fb443dea5dd42e393610433,
title = "Synthesis, in vitro hydrolysis, bioanalytical method development and pharmacokinetic study of an amide Prodrug of Ibuprofen",
abstract = "Ibuprofen, one of the most widely used non-steroidal anti-inflammatory drug, is an aryl acetic acid derivative, which is an active ingredient in variety of oral formulations such as tablets, gel, pellets, and syrup dosage forms used worldwide. Gastric side effects of ibuprofen are attributed to the presence of free - COOH group and inhibition of endogenous prostaglandins. In recent years, considerable research has been directed at designing prodrugs of ibuprofen with reduced gastro-intestinal toxicity. Numerous ester and amide prodrugs of ibuprofen have been reported. With this background, the present work involves the synthesis, analytical method development, in-vitro hydrolysis, bioanalytical method development, and pharmacokinetics study of an amide prodrug of Ibuprofen coded as TRB-559.",
keywords = "Analgesic, Bioanalytical Method Development, Drug Release, In Vitro Hydrolysis, Non- Steroidal Antiinflammatory Drugs, Pharmacokinetics, Pharmacokinetics Study, Prodrug, Prostaglandins, Validation",
author = "Ritu Ojha and Kunal Nepali and Rohit Goyal and Dhar, {Kanaya Lal} and Tilakraj Bhardwaj",
year = "2012",
month = "7",
day = "23",
doi = "10.2174/157341212801619333",
language = "English",
volume = "8",
pages = "261--271",
journal = "Current Pharmaceutical Analysis",
issn = "1573-4129",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Synthesis, in vitro hydrolysis, bioanalytical method development and pharmacokinetic study of an amide Prodrug of Ibuprofen

AU - Ojha, Ritu

AU - Nepali, Kunal

AU - Goyal, Rohit

AU - Dhar, Kanaya Lal

AU - Bhardwaj, Tilakraj

PY - 2012/7/23

Y1 - 2012/7/23

N2 - Ibuprofen, one of the most widely used non-steroidal anti-inflammatory drug, is an aryl acetic acid derivative, which is an active ingredient in variety of oral formulations such as tablets, gel, pellets, and syrup dosage forms used worldwide. Gastric side effects of ibuprofen are attributed to the presence of free - COOH group and inhibition of endogenous prostaglandins. In recent years, considerable research has been directed at designing prodrugs of ibuprofen with reduced gastro-intestinal toxicity. Numerous ester and amide prodrugs of ibuprofen have been reported. With this background, the present work involves the synthesis, analytical method development, in-vitro hydrolysis, bioanalytical method development, and pharmacokinetics study of an amide prodrug of Ibuprofen coded as TRB-559.

AB - Ibuprofen, one of the most widely used non-steroidal anti-inflammatory drug, is an aryl acetic acid derivative, which is an active ingredient in variety of oral formulations such as tablets, gel, pellets, and syrup dosage forms used worldwide. Gastric side effects of ibuprofen are attributed to the presence of free - COOH group and inhibition of endogenous prostaglandins. In recent years, considerable research has been directed at designing prodrugs of ibuprofen with reduced gastro-intestinal toxicity. Numerous ester and amide prodrugs of ibuprofen have been reported. With this background, the present work involves the synthesis, analytical method development, in-vitro hydrolysis, bioanalytical method development, and pharmacokinetics study of an amide prodrug of Ibuprofen coded as TRB-559.

KW - Analgesic

KW - Bioanalytical Method Development

KW - Drug Release

KW - In Vitro Hydrolysis

KW - Non- Steroidal Antiinflammatory Drugs

KW - Pharmacokinetics

KW - Pharmacokinetics Study

KW - Prodrug

KW - Prostaglandins

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=84863955168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863955168&partnerID=8YFLogxK

U2 - 10.2174/157341212801619333

DO - 10.2174/157341212801619333

M3 - Article

AN - SCOPUS:84863955168

VL - 8

SP - 261

EP - 271

JO - Current Pharmaceutical Analysis

JF - Current Pharmaceutical Analysis

SN - 1573-4129

IS - 3

ER -